Page 199 - Biomedical Engineering and Design Handbook Volume 2, Applications
P. 199

178  MEDICAL DEVICE DESIGN

                       TABLE 6.2  Examples of Various Marketed Controlled-Release Drug Delivery Products (Continued)
                                          Product                      Route of     Developer/
                        Design Principle  Name        Active Ingredient  Administration  Manufacturer
                       Thermally      ThermoDox      Doxorubicin     Parenteral  Celsion
                       triggered release
                       Pegylated systems  Macugen    Pegaptanib sodium   Parenteral   Pfizer/OSI
                                      Oncaspar       PEG−L-asparginase  L-asparginase  Enzon
                                      Adagen         PEG−Adenosine   Parenteral  Enzon
                                                      Deaminase
                                      PEGIntron      PEG−Interferon α2b  Parenteral  Schering Plough
                                      PEGASYS        PEG−Interferon α2a  Parenteral  Roche
                                      Neulasta       Pegfilgastrim   Parenteral  Amgen
                       Ligand-based   Herceptin      Trastuzumab     Parenteral  Genentech
                       targeted delivery  Avastin    Bevacizumab     Parenteral  Genentech
                                      Rituxan        Rituximab       Parenteral  Genentech/Biogen
                                                                                  Idec
                                      Raptiva        Efalizumab      Parenteral  Genentech
                                      Xolair         Omalizumab      Parenteral (sc)  Genentech/Novartis
                                      Remicade       IgG1κ (anti-TNFα)  Parenteral  Centocor
                                      Bexxar         Tositumomab     Parenteral  Glaxo Smith Kline
                                      Tysabri        Natalizumab     Parenteral  Biogen Idec/Elan
                                      Soliris        Eculizumab      Parenteral  Alexion
                       Programmable drug   Animas 2020   Insulin     Parenteral  J&J (Animas Corp.)
                       delivery systems  MiniMed Paradigm   Insulin  Parenteral  Medtronic
                                       REAL-Time
                                      CozMore        Insulin         Parenteral  Smiths Medical MD
                                       Insulin pump
                                       system
                                      Accu-Chek Spirit  Insulin      Parenteral  Roche
                                      OmniPod        Insulin         Parenteral  Insulet Corp.
                                      Amigo Nipro    Insulin         Parenteral  Nipro Diabetes
                                                                                  Systems


           REFERENCES

                       1. CDER 1999 Report to the Nation.  Improving Public Health Through Human Drugs. US Department of
                         Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research.
                       2. Y. E. Chien, Novel Drug Delivery Systems, 2d ed., Marcel Dekker, New York, 1992.
                       3. V. S. Gerogiannis, D. M. Rekkas, and P. P. Dallas, Floating and Swelling Characteristics of  Various
                         Excipients Used in Controlled-Release Technology, Drug Dev. Ind. Pharm. 19:1061–1081, 1993.
                       4. R. O. Potts and G. W. Cleary, Transdermal Drug Delivery: Useful Paradigms, J. Drug Target, 3(4):247–251,
                         1995.
                       5. J. R. Robinson and V. H. Lee (eds.), Controlled Drug Delivery: Fundamentals and Applications, 2d ed.,
                         Marcel Dekker, New York, 1987.
                       6. S. D. Bruck (ed.), Controlled Drug Delivery, vols. 1 and 2, CRC Press, Florida, 1984.
                       7. S. Cohen and H. Bernstein (eds.), Microparticulate Systems for Delivery of Proteins and Vaccines, Marcel
                         Dekker, New York, 1996.
                       8. H. Bundgaard (eds.), Design of Prodrugs, Elsevier Science, New York, 1985.
                       9. J. Crank, The Mathematics of Diffusion, 2d ed., Oxford Press, 1975.
   194   195   196   197   198   199   200   201   202   203   204